This site is intended for Healthcare Professionals only.

Apixaban witnessed £280m rise in its cost since 2021/22

Date:

Share post:

Atorvastatin, a medicine to treat high blood cholesterol, is the most dispensed drug with 59 million items in England in 2022/23, revealed the NHS Business Services Authority (NHSBSA) on Thursday (8 June).

While Apixaban (an anticoagulant) was the drug with the highest costs of £430 million. Apixaban 5mg tablets had the largest increase in cost between 2021/22 and 2022/23 in England, with an increase of £280 million.

NHSBSA’s annual statistics report ‘Prescription Cost Analysis-England 2022/23’ published also has revealed an eight per cent rise in the prescription items that were dispensed in the community in England.

The report highlighted that in 2022/23, 1.18 billion prescription items were dispensed at a cost of £10.4 billion in the community in England, witnessing an increase of eight per cent  from £9.69 billion in 2021/22.

Compared to 2014/15, the cost has increased by 17 per cent or £1.48 billion. This marks the fourth year in a row where the cost of items dispensed has increased, after seeing a decrease in the previous three years from 2015/16 to 2018/19.

The report also showed the number of drugs and medical devices (such as blood glucose monitors) dispensed in the community in England increased by 3 per cent to 1.18 billion, from 1.14 billion in 2021/22. Compared to 2014/15, this number has increased by 10 per cent.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Opioid overdose: Pharmacy professionals to be able to supply naloxone without a prescription

DHSC also publishes a new 10-year strategic plan to expand and improve the drug and alcohol workforce The...

New NHS patient choice scheme offers 5 options, but nursing shortages persist

Royal College of Nursing CE urges caution amidst new NHS patient choice pilot scheme rollout "Patients deserve choice, but...

Prof Ryan Donnelly awarded prestigious RPS Harrison Memorial Medal 2024

RPS HMM winner Professor Donnelly's work has secured £30M+ funding through his pioneering work in developing advanced polymeric...

Pharmacies forced to subsidise NHS medicines: NPA hands £108m invoice to DHSC

The NPA calls for a new deal that reverses “historical funding cuts and gives the sector the respect...